This article has multiple issues. Please help improve it or discuss these issues on the talk page. ( Learn how and when to remove these template messages) This article's lead section may be too long. Please read the length guidelines and help move details into the article's body. (April 2022) This biography of a living person relies too much on references to primary sources. Please help by adding secondary or tertiary sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libelous or harmful. Find sources:  "Karen Canfell" –  news · newspapers · books · scholar · JSTOR (April 2022) ( Learn how and when to remove this message) ( Learn how and when to remove this message)

Karen Canfell is an Australian epidemiologist and cancer researcher.

After being awarded a D.Phil. from Oxford in 2004 with a thesis entitled Use of hormone replacement therapy as a potential co-factor in the neoplastic progression of HPV-related cervical disease, ^[1] Canfell returned to Australia to work for the Cancer Council in Sydney where she continued to work on cervical cancer in particular ^{[2] [3] [4]} and all its ramifications, as well as the epidemiology of breast, ^{[5] [6]} and other cancers. ^{[7] [8] [9]}

With the advent of HPV vaccines and the mass HPV vaccination programs in Australia for girls (starting in 2007) and boys (starting in 2013) to prevent HPV infection, her interests turned to monitoring the effects of such programs, ^[10] appropriate screening for cervical cancer in Australia ^[11] and other countries. ^{[12] [13] [14]} A major focus has been how to do this effectively in developing and low-income countries ^{[15] [16] [17]} as well as in high-income countries. ^{[18] [19]}

Together with her team, her work was fundamental in Australia making the 2017 transition of their national cervical screening program from cytology (pap smears) to a 5-yearly HPV DNA-based screening, ^{[20] [21]} and her work both with respect to other countries and in Australia ^[22] means that Australia is on track to eliminate cervical cancer by 2028. ^[23]

Career

Canfell worked for the NSW Cancer Council from approximately 2004 to 2011. ^{[24] [7]} By 2012 Canfell was affiliated with both the Cancer Research Division of the Cancer Council and the School of Public Health at the University of Sydney. ^{[16] [25]} By 2013 she was a professor at UNSW (Prince of Wales Clinical School) ^[18] and continued there until at least 2019. ^[26]

From approximately 2020 she has been the director of The Daffodil Centre at the University of Sydney (a joint venture with the Cancer Council). ^[20] She is a co-leader of the World Health Organisation (WHO) Cervical Cancer Elimination Modelling Consortium. ^{[26] [20]}

Awards

In 2019 she became a Fellow of the Australian Academy of Health and Medical Science, ^[27] and in 2020 won an Elizabeth Blackburn Investigator grant award for leadership in Health Services Research. ^[20] In 2015 she won the NHMRC National Award for Research Excellence and was also nominated that year as a Woman of Influence by Westpac and the Australian Financial Review. ^[28]

In 2021 she was invited to give the prestigious Richard Doll Seminar at Oxford where she spoke as co-leader of the World Health Organisation (WHO) Cervical Cancer Elimination Modelling Consortium on the topic of the WHO's strategy for the elimination of cervical cancer ^[29] (The road to cervical cancer elimination). ^{[30] [31]}

References

External links

Scholia has a profile for Karen Canfell (Q70389126).

• WorldCat: Karen Canfell publications
• Karen Canfell publications indexed by Google Scholar